In the last two years, surveys of physicians show a wide spread consensus that Clostridia Difficile infections are becoming more common. What can be done to stop this emerging threat? Our guest is Dr. Clifford McDonald, a medical epidemiologist in the Epidemiology and Laboratory Branch, Division of Health Quality Promotion, CDC. He has investigated Clostridia Difficile outbreaks and written extensively on the subject.
The Epidemiology of Clostridium difficile
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
In the last two years, surveys of physicians show a wide spread consensus that Clostridia Difficile infections are becoming more common. What can be done to stop this emerging threat? Our guest is Dr. Clifford McDonald, a medical epidemiologist in the Epidemiology and Laboratory Branch, Division of Health Quality Promotion, CDC. He has investigated Clostridia Difficile outbreaks and written extensively on the subject.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
COVID-19: On The Frontlines
How COVID-19 Is Affecting Life Outside of the Office: A Dermatologist’s Experience
<p>How COVID-19 Is Affecting Life Outside of the Office: A Dermatologist’s Experience</p>
Medical Industry Feature
Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer
<p>Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
GI Insights
Advancing PBC Care: A Closer Look at Second-Line Therapies
<p>Advancing PBC Care: A Closer Look at Second-Line Therapies</p>
GI Insights
Crossroads in PBC Care: When First-Line Therapy Falls Short
<p>Crossroads in PBC Care: When First-Line Therapy Falls Short</p>
CME/CE
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
0.25 credits
<p>Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities</p>
CME/CE
Collaborative Insights to Solve the Puzzle of Bladder Cancer
1.00 credits
<p><span data-contrast="auto" style="list-style-type: disc;" xml:lang="EN-US">Collaborative Insights to Solve the Puzzle of Bladder Cancer</span></p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?